Persistent serum protein signatures define an inflammatory subcategory of long COVID
Aarthi Talla(Allen Institute for Immunology), Troy R. Torgerson(Allen Institute for Immunology)
Cited by 125
Related Papers
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
|Journal of Allergy and Clinical Immunology|2018|261
Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome
|Frontiers in Immunology|2018|186
Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
|Journal of Allergy and Clinical Immunology|2017|166
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts
|Journal of Allergy and Clinical Immunology|2014|150